Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $44
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Daniel Kutz maintains an Underweight rating on Helmerich & Payne (NYSE:HP) and raises the price target from $42 to $44.
October 17, 2023 | 2:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley maintains an Underweight rating on Helmerich & Payne and raises the price target from $42 to $44.
The Underweight rating maintained by Morgan Stanley indicates a negative outlook for Helmerich & Payne. However, the increase in price target from $42 to $44 suggests that the analyst sees some potential for the stock's price to rise, albeit not significantly. This could lead to a short-term negative impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100